Evidence map›Paper›PMID 34359550›Full record

ArticleCancers2021

The Bladder Microbiome Is Associated with Epithelial-Mesenchymal Transition in Muscle Invasive Urothelial Bladder Carcinoma.

Wei Tse Li, Anjali S Iyangar, Rohan Reddy, Jaideep Chakladar, Valmik Bhargava, Kyoko Sakamoto, Weg M Ongkeko, Mahadevan Rajasekaran

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06904573 (A Multicenter, Randomized Controlled Phase II Study of Evaluating the Efficacy and Safety of Immunotherapy Combined With Oral Probiotics Compound), which is not on this map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06904573 phase2recruitingnot on this mapstarted 2025, after this paper: background citation

A Multicenter, Randomized Controlled Phase II Study of Evaluating the Efficacy and Safety of Immunotherapy Combined With Oral Probiotics Compound (Biolosion) in Patients With Advanced Urothelial Carcinoma

TypeinterventionalSponsorSun Yat-sen UniversityRan2025 to 2028Enrolled222ConditionsAdvanced Urothelial Carcinoma, Probiotics, ImmunotherapyArmsProbiotics Compound (Biolosion), Nab-paclitaxel, Cisplatin, Gemcitabine, Disitamab vedotin
3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Review
  3. The emerging role of the microbiome in bladder cancer: prognostic implications and treatment response.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas · 2026
    Review
  4. Review
  5. Review
  6. The multi-kingdom cancer microbiome.Nature microbiology · 2025
    Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Research progress on the microbiota in bladder cancer tumors.Frontiers in cellular and infection microbiology · 2024
    Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Wei Tse LiDepartment of Surgery, Division of Otolaryngology-Head and Neck Surgery, UC San Diego School of Medicine, San Diego, CA 92093, USA.
Anjali S IyangarDepartment of Surgery, Division of Otolaryngology-Head and Neck Surgery, UC San Diego School of Medicine, San Diego, CA 92093, USA.
Rohan ReddyDepartment of Urology, San Diego VA Healthcare System, University of California, San Diego, CA 92161, USA.
Jaideep ChakladarDepartment of Surgery, Division of Otolaryngology-Head and Neck Surgery, UC San Diego School of Medicine, San Diego, CA 92093, USA.
Valmik BhargavaDivision of Cardiology, San Diego VA Healthcare System, University of California, San Diego, CA 92161, USA.
Kyoko SakamotoDepartment of Urology, San Diego VA Healthcare System, University of California, San Diego, CA 92161, USA.
Weg M OngkekoDepartment of Surgery, Division of Otolaryngology-Head and Neck Surgery, UC San Diego School of Medicine, San Diego, CA 92093, USA.ORCID 0000-0002-2790-2480
Mahadevan RajasekaranDepartment of Urology, San Diego VA Healthcare System, University of California, San Diego, CA 92161, USA.
University of California San Diego · US

Funding

UC San Diego Academic Senate RG096474
6 · The paper itself

Abstract

The intra-tumor microbiome has recently been linked to epithelial-mesenchymal transition (EMT) in a number of cancers. However, the relationship between EMT and microbes in bladder cancer has not been explored. In this study, we profiled the abundance of individual microbe species in the tumor samples of over 400 muscle invasive bladder carcinoma (MIBC) patients. We then correlated microbe abundance to the expression of EMT-associated genes and genes in the extracellular matrix (ECM), which are key players in EMT. We discovered that a variety of microbes, including

Indexed as

bladder cancerBLCAECMelastinEMTintratumor microbiomeMIBCmicrobiome

Identifiers

PMID34359550
PMCPMC8344975
OpenAlexW3185250025

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.